Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1111/bjh.16815 http://scihub22266oqcxt.onion/10.1111/bjh.16815 32428242!7276733!32428242     free     free     free Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Br+J+Haematol 2020 ; 190 (2): 173-178 Nephropedia Template TP {{tp|p=32428242|t=2020. COVID-19 and myeloma: what are the implications for now and in the future?|pdf=|usr=}}{{32428242}} gab.com Text COVID-19 and myeloma: what are the implications for now and in the future JO: Br J Haematol http://www.kidney.de/pget.php?&tw=1&pmid=32428242 #FOAvip The pandemic has affected every aspect of myeloma care. Immediate focus is minimising risk of contracting coronavirus disease 2019 (COVID-19) and the sequelae of infection. However, what does the future hold for our patients? What lessons will be taken forward to tackle myeloma in the fiscally constrained future? If we embrace the challenges that will emerge in the post-pandemic environment, the treatment delivered to patients could be more cost-effective and better tailored than before. Healthcare delivery post-COVID-19 will not return to how it was, and now is the time to invest in novel strategies to deliver the best possible outcomes for patients. Twit Text FOAVip COVID-19 and myeloma: what are the implications for now and in the future ????Br J Haematol http://www.kidney.de/pget.php?&tw=1&pmid=32428242 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32428242 #FOAvip English Wikipedia <ref>{{Cite pmid|32428242}}</ref> COVID-19 and myeloma: what are the implications for now and in the future? #MMPMID32428242 Freeman CL; Mikhael J Br J Haematol 2020[Jul]; 190 (2): 173-178 PMID32428242show ga The pandemic has affected every aspect of myeloma care. Immediate focus is minimising risk of contracting coronavirus disease 2019 (COVID-19) and the sequelae of infection. However, what does the future hold for our patients? What lessons will be taken forward to tackle myeloma in the fiscally constrained future? If we embrace the challenges that will emerge in the post-pandemic environment, the treatment delivered to patients could be more cost-effective and better tailored than before. Healthcare delivery post-COVID-19 will not return to how it was, and now is the time to invest in novel strategies to deliver the best possible outcomes for patients. |Adrenal Cortex Hormones[MESH] |Betacoronavirus[MESH] |COVID-19[MESH] |Coronavirus Infections/*epidemiology[MESH] |Delivery of Health Care/*methods[MESH] |Drug Costs[MESH] |Humans[MESH] |Immunosuppression Therapy[MESH] |Multiple Myeloma/*therapy[MESH] |Pandemics[MESH] |Pneumonia, Viral/*epidemiology[MESH] |Risk Factors[MESH] |SARS-CoV-2[MESH]COVID-19 and myeloma: what are the implications for now and in the fut(epmc).pdf DeepDyve Pubget Overpricing